Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Xiaoning Zeng (Nanjing, China), Xiaoning Zeng, Yuan Ma, Hao Gu, Yihang Gu, Mao Huang. The effect of oligomeric proanthocyanidin on airway microenvironment in asthma. Eur Respir J 2016; 48: Suppl. 60, 4100

Member's Comments

No comment yet.

Related content which might interest you: Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Chronic dosing effects of propranolol in asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 The multicomponent nature of difficult asthma Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Investigating airway HMGB1 redox state in health and asthma Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 The effect of inhaled ciclesonide on airway blood flow Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 Tiotropium for uncontrolled asthma (a meta-analysis) Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Characterisation of asthma patients with persistent airflow obstruction Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Vitamin D and airway obstruction in an urban Irish asthmatic population Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 An extensive function evaluation in severe asthma with airflow limitation Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Effect of roflumilast on airway remodeling in a murine model of chronic asthma Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Investigating the role of BAFF in murine models of allergic asthma Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Phenotypic characteristics of asthma with small airways involvement Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 The impact of bacterial lysate on asthma prevention in mouse and its mechanism Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 ADEPT-derived, U-BIOPRED validated asthma clinical clusters with Th2 and non-Th2 phenotypes Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014